‘A False Sense of Security’? Understanding the Role of the Hpv Vaccine on Future Cervical Screening Behaviour: A Qualitative Study of Uk Parents and Girls of Vaccination Age
Author(s) -
Lorna Henderson,
Alison Clements,
Sarah Damery,
Clare Wilkinson,
Joan Austoker,
Sue Wilson Group
Publication year - 2011
Publication title -
journal of medical screening
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.515
H-Index - 64
eISSN - 1475-5793
pISSN - 0969-1413
DOI - 10.1258/jms.2011.010148
Subject(s) - medicine , vaccination , cervical screening , cervical cancer , family medicine , human papillomavirus , qualitative research , hpv infection , gynecology , immunology , cancer , social science , sociology
The UK Human Papillomavirus (HPV) vaccination programme was introduced in 2008 for girls aged 12-13. The vaccine offers protection against HPV types 16 and 18, which together cause about 70% of cervical cancers. Vaccinated girls will receive future invitations to the NHS Cervical Screening Programme, to prevent cancers associated with HPV types not included in the vaccine, and in case of prior infection with HPV 16 or 18. Little is known about parents' and girls' understandings of the protection offered by the vaccine, or the need for future screening.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom